Literature DB >> 33772573

Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2.

Peng Wu1,2, Fengfeng Liu3, Zhaorui Chang3, Yun Lin1, Minrui Ren3, Canjun Zheng3, Yu Li3, Zhibin Peng3, Yin Qin3, Jianxing Yu3, Mengjie Geng3, Xiaokun Yang3, Hongting Zhao3, Zhili Li3, Sheng Zhou3, Lu Ran3, Benjamin J Cowling1,2, Shengjie Lai4, Qiulan Chen3, Liping Wang3, Tim K Tsang1, Zhongjie Li3.   

Abstract

BACKGROUND: The relative contributions of asymptomatic, pre-symptomatic and symptomatic transmission of SARS-CoV-2 have not been clearly measured although control measures may differ in response to the risk of spread posed by different types of cases.
METHODS: We collected detailed information on transmission events and symptom status based on laboratory-confirmed patient data and contact tracing data from four provinces and one municipality in China. We estimated the variation in risk of transmission over time, and the severity of secondary infections, by symptomatic status of the infector.
RESULTS: There were 393 symptomatic index cases with 3136 close contacts and 185 asymptomatic index cases with 1078 close contacts included into the study. The secondary attack rate among close contacts of symptomatic and asymptomatic index cases were 4.1% (128/3136) and 1.1% (12/1078), respectively, corresponding to a higher transmission risk from symptomatic cases than from asymptomatic cases (OR: 3.79, 95% CI: 2.06, 6.95). Approximately 25% (32/128) and 50% (6/12) of the infected close contacts were asymptomatic from symptomatic and asymptomatic index cases, respectively, while more than one third (38%) of the infections in the close contacts of symptomatic cases were attributable to exposure to the index cases before symptom onset. Infected contacts of asymptomatic index cases were more likely to be asymptomatic and less likely to be severe.
CONCLUSIONS: Asymptomatic and pre-symptomatic transmission play an important role in spreading infection, although asymptomatic cases pose a lower risk of transmission than symptomatic cases. Early case detection and effective test-and-trace measures are important to reduce transmission.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asymptomatic; pre-symptomatic; symptomatic; transmission

Year:  2021        PMID: 33772573      PMCID: PMC8083716          DOI: 10.1093/cid/ciab271

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic.

Authors:  Yutong Wang; Ke Zheng; Wenjing Gao; Jun Lv; Canqing Yu; Lan Wang; Zijun Wang; Bo Wang; Chunxiao Liao; Liming Li
Journal:  Med Rev (Berl)       Date:  2022-02-24

2.  Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  JAMA Netw Open       Date:  2021-08-02

3.  Why do some coronaviruses become pandemic threats when others do not?

Authors:  Benjamin L Rice; Justin Lessler; Clifton McKee; C Jessica E Metcalf
Journal:  PLoS Biol       Date:  2022-05-16       Impact factor: 9.593

4.  Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19.

Authors:  Seongman Bae; Ji Yeun Kim; So Yun Lim; Heedo Park; Hye Hee Cha; Ji-Soo Kwon; Mi Hyun Suh; Hyun Jung Lee; Joon Seo Lim; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Ho Young Lee; Sohyun Lee; Man-Seong Park; Sung-Han Kim
Journal:  Viruses       Date:  2021-10-22       Impact factor: 5.048

5.  COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.

Authors:  Helena C Maltezou; Periklis Panagopoulos; Flora Sourri; Theodoros V Giannouchos; Vasilios Raftopoulos; Maria N Gamaletsou; Amalia Karapanou; Dimitra-Maria Koukou; Athanasia Koutsidou; Emmanuela Peskelidou; Konstantina Papanastasiou; Kyriakos Souliotis; Athanasia Lourida; Nikolaos V Sipsas; Dimitrios Hatzigeorgiou
Journal:  Vaccine       Date:  2021-10-30       Impact factor: 3.641

6.  Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.

Authors:  George J Milne; Julian Carrivick; David Whyatt
Journal:  BMC Med       Date:  2022-02-18       Impact factor: 8.775

7.  Singing Is a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case-Control Study of Karaoke-Related Coronavirus Disease 2019 Outbreaks in 2 Cities in Hokkaido, Japan, Linked by Whole Genome Analysis.

Authors:  Manami Nakashita; Yuta Takagi; Hiroyuki Tanaka; Haruna Nakamura; Yusuke Serizawa; Tomohiko Ukai; Kotaro Azuma; Hiroko Chiba; Kensaku Terada; Kaori Nakanishi; Tomoko Fujikawa; Kayoko Saito; Ryo Yamaguchi; Yuu Mitsuhashi; Koichi Yano; Tomoko Shibuma; Akemi Kuzuma; Shinichiro Tsuda; Terukazu Sadamoto; Yasuhiko Ishii; Tsukasa Ohara; Yoshiaki Hitomi; Takashi Hiroshima; Takuya Yamagishi; Hajime Kamiya; Anita Samuel; Yuichiro Yahata; Tomoe Shimada; Yuzo Arima; Motoi Suzuki; Tsuyoshi Sekizuka; Makoto Kuroda; Tomimasa Sunagawa
Journal:  Open Forum Infect Dis       Date:  2022-03-23       Impact factor: 4.423

8.  SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in Japan.

Authors:  Junna Oba; Hiroaki Taniguchi; Masae Sato; Masaki Takanashi; Moe Yokemura; Yasunori Sato; Hiroshi Nishihara
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

Review 9.  Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19).

Authors:  Ting Wu; Shuntong Kang; Wenyao Peng; Chenzhe Zuo; Yuhao Zhu; Liangyu Pan; Keyun Fu; Yaxian You; Xinyuan Yang; Xuan Luo; Liping Jiang; Meichun Deng
Journal:  Front Med (Lausanne)       Date:  2021-07-06

10.  Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.

Authors:  Min Kang; Hualei Xin; Jun Yuan; Sheikh Taslim Ali; Zimian Liang; Jiayi Zhang; Ting Hu; Eric Hy Lau; Yingtao Zhang; Meng Zhang; Benjamin J Cowling; Yan Li; Peng Wu
Journal:  Euro Surveill       Date:  2022-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.